Covid-19 vaccinated pregnant women pass protection to newborns

A new study has found that women who receive the mRNA Covid-19 vaccine during pregnancy pass high levels of antibodies to their babies. The findings of the study were published in the 'American Journal of Obstetrics and Gynecology MFM'. Antibodies can either be produced as part of the natural response to infection or triggered by vaccines. Additional research is needed to determine how effective the infant antibodies are, how long protection will last, and if vaccination in the second half of pregnancy may confer higher levels of antibody transfer than earlier. Future studies should also focus on antibody transmission to newborns in a larger population and the durability of antibody detection during infancy.